Objective: To evaluate the efficacy of probiotics in reducing the rates of nosocomial infection in pediatric intensive care.
Design: Randomized, double-blind, placebo-controlled trial.
Setting: A 16-bed pediatric intensive care unit in a university-affiliated children's hospital.